63 In a large-scale real-world study, the use of GLP-1 receptor agonists in patients with T2DM was also shown to increase the risk of intestinal obstruction compared to sodiumglucose cotransporter-2 (SGLT-2) inhibitors
Semaglutide GLP-1 is an effective weight loss solution, but results take time
Independent of ASCVD and other risk factors, such as hypertension, diabetes also increases the risk of heart failure [13]
Each time we breathe in, we sample odorant molecules in the environment that enable us to detect the presence of objects that may be of value in terms of our protection, our diet or our relationships with others, explains Moustafa Bensafi, CNRS research professor within the Neuropop team of the Lyon Neuroscience Research Centre (CNRL)1
Your doctor may need to adjust your GLP-1 dose, temporarily discontinue therapy, or investigate alternative causes for your symptoms